DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Ridker PM, Thuren T, Zalewski A et al.
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
Am Heart J 2011;
162: 597-605
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.